✦ LIBER ✦
273 Is PSA doubling time reliable as a progression risk criterion for patients with low-risk prostate cancer in an active surveillance programme?
✍ Scribed by Thomsen, F.B.; Christensen, I.J.; Røder, M.A.; Brasso, K.; Iversen, P.
- Book ID
- 122520942
- Publisher
- Elsevier Science
- Year
- 2013
- Tongue
- English
- Weight
- 176 KB
- Volume
- 12
- Category
- Article
- ISSN
- 1569-9056
No coin nor oath required. For personal study only.